123I-3BNC117

N/A

Report date: 2025/10/20 14:38:48

NME

Base Information

Drug Name123I-3BNC117

Drug Alias Name123I Radiolabeled 3BNC117123I-3BNC117

ClassificationRadiation-emitting products > Nuclides > Iodine > 123IRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionHIV envelope protein gp120 modulators

TargetsHIV envelope protein gp120

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLausanne University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLausanne University Hospital

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A